Dr. Alisha Noreen Lecturer Iqra University

Dr.
Alisha Noreen
Lecturer
Iqra University
Distribution
Different Forms of Calcium
Most of the calcium in the body exists as the mineral
hydroxyapatite, Ca10(PO4)6(OH)2.
 Calcium in the plasma:

45% in ionized form (the physiologically active form)
45% bound to proteins (predominantly albumin)
10% complexed with anions (citrate, sulfate, phosphate)
 Both total calcium and ionized calcium

measurements are available in many laboratories
Body requirements
Age (in years) Calcium Requirement

1–3 500mg
4-8 800mg
9 - 18 1300mg
19 - 50 1000mg
51+ 1500mg
*Pregnant and lactating women are recommended

a daily calcium intake of 1000mg.
source
 Calcium is found in milk and dairy products,
 Green leafy vegetables,
 seafood,
 almonds,
 blackstrap molasses,
 broccoli,
 enriched soy and rice milk products, figs,
 soybeans and tofu.
Absorption of Ca
 Absorption is taking place from the first and second part of duodenum
against concentration gradients
 Absorption required a carrier protein , helped by Ca-dependent ATPase
 Increased absorption-
- calcitriol , active form of Vit-D
- PTH
- acidic pH
- Lys and Arg
 Inhibiting absorption -
 phytic acid
 oxalates
 phosphate
 Mg
 caffeine
Biological functions of Calcium
 Bone and teeth mineralization
 Regulate neuromuscular excitability
 Blood coagulation
 Secretory processes
 Membrane integrity
 Plasma membrane transport
 Enzyme reactions
 Release of hormones and neurotransmitters
 Intracellular second messenger
Calcium turnover
Hormone regulation of calciummetabolism
Vitamin D
Parathyroid hormone Calcitonin

(PTH)
Organ-target: bones, kidneys Organ-target - bones
Function of PTH - increase of Ca

concentration in plasma Function - decrease of Ca
concentration in
Mechanisms: plasma
1. Releasing of Са by bones
(activation of osteoclasts –
resumption of bones)
2. Increase of Са reabsorbing in
kidneys
3. Activation of vit. Dз synthesis
and increase of absorption
in the intestine
Vitamin D3
 Dietary cholesterol is converted into 7-dehydrocholesterol and
transported to skin
 UV sunlight (290-320nm) penetrates the skin to break
provitamine ( 7-dehydrocholesterol ) to previtamine and it is
then converted to Cholecalciferol by the process of
isomerisation
 In the liver, cholecalciferol undergoes 25-hydroxylation to yield
25(OH) Vit-D ( calcidiol)
 In the kidney , calcidiol undergoes further 1α-hydroxylation to
produce 1,25 –dihydroxy Vit-D (Calcitriol). Its production in the
kidney is catalyzed by 1α -hydroxylase .
1α -hydroxylase activity is increased by :
Decreased serum Ca2+
Increased PTH level
Decreased serum phosphate
Action of 1,25-
dihydroxycholecalcififerol(Calcitriol)
 Increases intestinal Ca2+ absorption
 Increases intestinal phosphate absorption
 Increase renal reabsorption of Ca2+ and
phosphate
 Increases osteoclast activity
Vitamin D3 and Calcium Control
 Vitamin D3 (Cholecalciferol)
 Converted to precursor in liver
 Initially stored
 Converted to 25-Hydroxycholecalciferol
 Feedback control limits concentration
 Converted to active form in kidney
 1,25-Dihydroxycholecalciferol
 Under the feedback control of parathyroid hormone (PTH)
 The main action of 1,25-(OH)2-D is to stimulate absorption of

Ca2+ from the intestine.
 1,25-(OH)2-D induces the production of calcium binding
proteins which sequester Ca2+, buffer high Ca2+ concentrations
that arise during initial absorption and allow Ca2+ to be
absorbed against a high Ca2+ gradient
Vitamin D3 and Calcium Control
Vitamin D3 promotes intestinal calcium
absorption
 Vitamin D3 acts via steroid hormone like receptor to
increase transcriptional and translational activity
 One gene product is calcium-binding protein (CaBP)
 CaBP facilitates calcium uptake by intestinal cells
 Estrogen, prolactin and growth hormone also
stimulate 1α -hydroxylase thus increasing Ca
absorption during pregnancy, lactation and
growth
Vitamin D3 Actions on Bones
 Another important target for 1,25-(OH)2-D3 is the bone.
 Osteoblasts, but not osteoclasts have vitamin D3 receptors.
 1,25-(OH)2-D3 acts on osteoblasts which produce a
paracrine signal that activates osteoclasts to resorb Ca++
from the bone matrix.
 1,25-(OH)2-D3 also stimulates osteocytic osteolysis.
 In its absence, excess osteoid accumulates from lack of 1,25-
(OH)2-D3 repression of osteoblastic collagen synthesis.
 Inadequate supply of vitamin D3 results in rickets, a
disease of bone deformation
):
Parathyroid hormone (PTH
 It is synthesised as pre-pro-PTH(115aa) and is
cleaved to pro-PTH(90aa) with cleavage before
secretion of PTH(84aa).
 Intact PTH T1/2 3-4 mins
 Normal levels 1.3 – 6.8 pmol/L
 Secreted from the chief cells of the parathyroid glands.
 Function:
Increase renal phosphate excretion , and increases plasma calcium by:
 Increasing osteoclastic resorption of bone (occurring rapidly).
 Increasing intestinal absorption of calcium (a slower response).
 Increasing synthesis of 1,25-(OH)2D3 (stimulating GIT absorption).
 Increasing renal tubular reabsorption of calcium
PTH action
 The overall action of PTH is to increase plasma Ca++
levels and decrease plasma phosphate levels.
 PTH acts directly on the bones to stimulate Ca++
resorption and kidney to stimulate Ca++ reabsorption in
the distal tubule of the kidney and to inhibit
reabosorptioin of phosphate (thereby stimulating its
excretion).
 PTH also acts indirectly on intestine by stimulating 1,25-
(OH)2-D synthesis.
 PTH indirectly increases Calcium absorption from GIT
Regulation of PTH
 The dominant regulator of PTH is plasma Ca2+.
 Secretion of PTH is inversely related to [Ca2+].
 Maximum secretion of PTH occurs at plasma Ca2+ below 3.5
mg/dL.
 At Ca2+ above 5.5 mg/dL, PTH secretion is maximally inhibited.
 PTH secretion responds to small alterations in plasma Ca2+ within
seconds.
 A unique calcium receptor within the parathyroid cell plasma
membrane senses changes in the extracellular fluid concentration
of Ca2+.
 This is a typical G-protein coupled receptor that activates
phospholipase C and adenylate cyclase—result is increase
in intracellular Ca2+ via generation of inositol phosphates
and decrease in cAMP which prevents exocytosis of PTH
from secretory granules.
 When Ca2+ falls, cAMP rises and PTH is secreted.
 1,25-(OH)2-D inhibits PTH gene expression, providing
another level of feedback control of PTH.
 Despite close connection between Ca2+ and PO4, no direct
control of PTH is exerted by phosphate levels.
Calcitonin
 This is produced from the C-cells of the thyroid.
 Ploypeptide(32 aa) , MW 35KD , T1/2 10 mins
 The major stimulus of calcitonin secretion is a rise in
plasma Ca++ levels
 Calcitonin is a physiological antagonist to PTH with
regard to Ca++ homeostasis
 The target cell for calcitonin is the osteoclast.
 Calcitonin acts via increased cAMP concentrations to
inhibit osteoclast motility and cell shape and inactivates
them.
 The major effect of calcitonin administration is a rapid
fall in Ca2+ caused by inhibition of bone resorption.
21
22

Dr. Alisha Noreen Lecturer Iqra University

Uploaded by

Copyright:

Available Formats

Dr. Alisha Noreen Lecturer Iqra University

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Dr. Alisha Noreen Lecturer Iqra University

Uploaded by

Copyright:

Available Formats

Dr.

 Calcium in the plasma:

45% bound to proteins (predominantly albumin)

10% complexed with anions (citrate, sulfate, phosphate)

 Both total calcium and ionized calcium

Age (in years) Calcium Requirement

*Pregnant and lactating women are recommended

Parathyroid hormone Calcitonin

Function of PTH - increase of Ca

 The main action of 1,25-(OH)2-D is to stimulate absorption of

You might also like